A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic and regimens as first-line therapy for advanced colorectal cancer

Kamel Bouzid, S. Khalfallah, J. Tujakowski, B. Piko, G. Purkalne, S. Plate, P. Padrik, M. Serafy, E. M. Pshevloutsky, B. Boussard, P. P. Bapsy, S. Ben Ahmed, T. Salek, S. Doneo, D. A. Gerges, D. C. Doval, E. Buyukunal, I. N. Chernozemsky, V. I. Tzekova, H. A. El-AzimH. Errihani, R. Samlali, J. S. Godz, N. Ghilezan, B. A. Berdov, G. N. Tchaikovsky, M. Wagnerova, N. F. Aykan, J. Zidan, G. Chachine

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic and regimens as first-line therapy for advanced colorectal cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases